Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

Scientists find new potential drug targets for neurodegenerative diseases

By Brian Buntz | February 11, 2022

Franco Lab

Maria Clara “Maca” Franco, center, with Kyle Nguyen, left, and Lydia Bastian. Franco’s research investigates neurodegenerative diseases. Image courtesy of Oregon State University.

Researchers at Oregon State University (OSU) have discovered a new class of potential drug targets for diseases like Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS).

The scientists are working to identify the best method to attack the targets — oxidized proteins. The most potent oxidant of the bunch is peroxynitrite, which is produced in conditions involving inflammation. Oxidized proteins and free radicals can damage DNA, lipids and proteins implicated in neurodegenerative diseases and other conditions.

Peroxynitrite is produced thanks to the diffusion-limited reaction of nitric oxide and superoxide.

Peroxynitrite appears to be especially pernicious when it oxidizes heat shock protein 90 (Hsp90), leading to signal activation that results in apoptosis or cell death.

The peroxynitrite ion plays a role in neuronal death in various central nervous system conditions such as stroke, multiple sclerosis and spinal cord injury.

“Now we know that the oxidation of different parts of Hsp90 can elicit different toxic functions in the protein,” said Maria Clara Franco, an assistant professor at OSU.

“By understanding the ways that oxidation modifies the Hsp90 structure and how the oxidized protein works in the cells, we can look for drugs that bind to the modified structure of Hsp90 and stop its toxic function without affecting the activity of normal Hsp90 in healthy tissues,” Franco said in a statement. “That means such drugs should have minimal to no side effects.”

The researchers had concluded that peroxynitrite was implicated in the death of motor neurons.

Their research was published in Redox Biology.

A separate group of researchers at Oregon State University recently found that certain cannabinoids may protect against COVID-19 infection. 


Filed Under: Neurological Disease
Tagged With: ALS, Alzheimer’s, amyotrophic lateral sclerosis, neurodegenerative diseases, Oregon State University, Parkinson's
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Aduhelm
Nine out of ten U.S. neurologists have Aduhelm efficacy doubts
Athira Pharma
​​Athira Pharma to continue open-label Alzheimer’s extension studies
Biogen
Biogen CEO Michel Vounatsos to step aside as Aduhelm sales continue to sputter
Janssen
Why Janssen’s nipocalimab could represent a ‘pipeline in a pathway’

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50